The possible role of autoimmunity in the pathogenesis of diabetes in β-thalassemia major

Diabetes and Metabolism

Volumn 27, Issue 2 I, 2001, Pages 149-154

  Monge, L ^a   Pinach, S ^a   Caramellino, L ^a   Bertero, M T ^a   Dall'Omo, A ^a   Carta, Q ^a  

^a UOA Diabetologia   (Italy)

Author keywords

Diabetes; GAD; ICA; Iron; Thalassemia

Indexed keywords

ANTINUCLEAR ANTIBODY; ENZYME ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; BETA THALASSEMIA; BLOOD TRANSFUSION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; OXIDATION; PANCREAS ISLET CELL; PATHOGENESIS;

ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNITY; BETA-THALASSEMIA; BLOOD TRANSFUSION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GLUTAMATE DECARBOXYLASE; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INSULIN ANTIBODIES; ISLETS OF LANGERHANS; MALE;

EID: 0035001995     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Long-term chelation therapy in thalassaemia major: Effect on liver iron concentration, liver histology and clinical progress
2. Endocrine abnormalities in thalassaemia major
3. Survival and causes of death in cirrhotic and noncirrhotic patients with primary haemochromatosis
4. Clinical consequences of acquired transfusional iron overload in adults
5. Italian Working Group on Endocrine Complications in Non-Endocrine Diseases: Multicenter study on prevalence of endocrine complications in thalassemia major
6. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major
7. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion
8. Insulin resistance and hyperinsulinemia in homozygous β-thalassemia
9. Diabetes and haemochromatosis: Current concepts, management and prevention
10. Desferrioxamine treatment prevents chronic islet allograft damage
11. Beta-cell secretion in patients with thalassemia major
12. The haemochromatotic human pancreas: A quantitative immunohistochemical and ultrastructural study
13. Role of α and β cells in the impaired glucose tolerance of thalassaemic subjects
14. The Expert Committee on the diagnosis and classification of diabetes mellitus: Report of the Expert Committee on the diagnosis and classification of diabetes mellitus
15. Glycemic control and complications in Type II diabetes. Design of a feasibility trial
16. Can islet cell antibodies predict IDDM in the general population?
17. Competitive insulin autoantibody assay: Prospective evaluation of subjects at high risk for development of Type I diabetes mellitus
18. Disease sensitivity and specificity of fifty-two assays for glutamic acid decarboxylase antibodies: The second international GADAb workshop
19. A simple salting-out procedure for extraction DNA from human nucleated cells
20. HLA Class II typing by PCR-SSOP: 12th International Histocompatibility Workshop experience
21. Insulin dependent diabetes in thalassaemia
22. Abnormal glucose tolerance in β-thalassemia major
23. Clinical and subclinical organ-specific autoimmune manifestations in Type I (insulin-dependent) diabetic patients and their first-degree relatives
24. Interleukin-1-beta, tumor necrosis factor-alpha, islet-cell antibody, and insulin secretion in children with thalassemia major on long-term blood transfusion
25. Comparaison des divers types d'anticorps anti-ìlots dans le diabète en fonction de la cause et de la durée d'evolution
26. Zinc deficiency and cell-mediated and humoral autoimmunity of insulin-dependent diabetes inthalassemic subjects
27. Concentration of insulin autoantibodies at onset of type 1 diabetes: Inverse linear correlation with age
28. Evaluation of antibodies to hepatitis C virus in a long-term prospective study of posttransfusion hepatitis among thalassemic children: Comparison between first- and second-generation assay
29. Evidence for a link between hepatitis C virus infection and diabetes mellitus in cirrhotic population
30. Antibodies to GAD in diabetic patients with chronic hepatitis C